1.Clinical features and TTC21B genotype of a child with nephronophthisis type 12.
Shan JIAN ; Qi-Jiao WEI ; Yu-Tong LIU ; Wei WANG ; Yu ZHOU ; Mei-Ying QUAN ; Yan-Yan HE ; Hong-Mei SONG ; Min WEI
Chinese Journal of Contemporary Pediatrics 2019;21(6):580-584
Nephronophthisis (NPHP) is a group of autosomal recessive tubulointerstitial cystic kidney disorders. This article reports a case of NPHP type 12 caused by TTC21B mutations. The girl had an insidious onset, with moderate proteinuria, renal dysfunction, stage 2 hypertension, situs inversus, and short phalanges when she visited the hospital for the first time at the age of 3 years and 6 months. The renal lesions progressed to end-stage renal disease (ESRD) before she was 4 years old. Urine protein electrophoresis showed glomerular proteinuria. There were significant increases in urinary β2-microglobulin and α1-microglobulin. Gene detection revealed two compound heterozygous mutations, c.1552T>C (p.C518R) and c.752T>G (p.M251R), in the TTC21B gene, which came from her father and mother respectively. The c.752T>G mutation was a novel mutation. It is concluded that besides typical tubular changes of NPHP, marked glomerular damage is also observed in patients with TTC21B gene mutations.
Child, Preschool
;
Female
;
Genotype
;
Humans
;
Kidney
;
Kidney Diseases, Cystic
;
Kidney Failure, Chronic
;
Microtubule-Associated Proteins
;
genetics
;
Mutation
;
Nephrosis
;
genetics
2.Clinical phenotype analysis of 6 cases of TTC21B gene related nephronophthisis.
Jing ZHANG ; Lei SUN ; Xin Yu KUANG ; Yu Lin KANG ; Sheng HAO ; Dan FENG ; Xiao Ling NIU ; Wen Yan HUANG
Chinese Journal of Pediatrics 2022;60(8):820-824
Objective: To analyze the clinical characteristics of 6 children with TTC21B-related nephronophthisis to provide reference for early clinical diagnosis. Methods: The general condition, clinical manifestations, laboratory tests and other clinical data of 6 children from 4 families diagnosed with nephronophthisis by genetic testing in Shanghai Children's Hospital from January 2015 to December 2020 were analyzed retrospectively. Results: A total of 6 children (3 males and 3 females) developed proteinuria and progressive renal dysfunction in early infancy. The onset age of proteinuria was 18 (6, 25) months. The age at the onset of renal impairment was 22 (10, 36) months. All 6 children progressed to end-stage renal disease (ESRD) within 10 (4, 65) months of onset. Five children had hypertension, 3 children with abnormal liver function, 2 children with visceral translocation and 1 child with growth retardation. The genetic results suggested that all children carried variations TTC21B gene p.C518R. Conclusions: Children with TTC21B gene p.C518R nephronophthisis had proteinuria and progressed to ESRD at the early stage of life. These nephronophthisis patients commonly presented with liver and renal dysfunction.
China
;
Female
;
Humans
;
Kidney Diseases, Cystic/genetics*
;
Kidney Failure, Chronic/genetics*
;
Male
;
Phenotype
;
Proteinuria/genetics*
;
Retrospective Studies
4.Long-term auditory monitoring in children with Alport syndrome based on different degrees of renal injury.
Lining GUO ; Wei LIU ; Min CHEN ; Jiatong XU ; Ning MA ; Xiao ZHANG ; Qingchuan DUAN ; Shanshan LIU ; Xiaoxu WANG ; Junsong ZHEN ; Xin NI ; Jie ZHANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2024;38(1):44-49
Objective:To investigate long-term auditory changes and characteristics of Alport syndrome(AS) patients with different degrees of renal injury. Methods:Retrospectively analyzing clinical data of patients diagnosed AS from January 2007 to September 2022, including renal pathology, genetic detection and hearing examination. A long-term follow-up focusing on hearing and renal function was conducted. Results:This study included 70 AS patients, of which 33(25 males, 8 females, aged 3.4-27.8 years) were followed up, resulting in a loss rate of 52.9%.The follow-up period ranged from 1.1to 15.8 years, with 16 patients followed-up for over 10 years. During the follow-up, 10 patients presenting with hearing abnormalities at the time of diagnosis of AS had progressive hearing loss, and 3 patients with new hearing abnormalities were followed up, which appeared at 5-6 years of disease course. All of which were sensorineural deafness. While only 3 patients with hearing abnormalities among 13 patients received hearing aid intervention. Of these patients,7 developed end-stage renal disease(ESRD), predominantly males (6/7). The rate of long-term hearing loss was significantly different between ESRD group and non-ESRD group(P=0.013). There was no correlation between the progression of renal disease and long-term hearing level(P>0.05). kidney biopsies from 28 patients revealed varying degrees of podocyte lesion and uneven thickness of basement membrane. The severity of podocyte lesion was correlated with the rate of long-term hearing loss(P=0.048), and there was no correlation with the severity of hearing loss(P>0.05). Among 11 cases, theCOL4A5mutationwas most common (8 out of 11), but there was no significant correlation between the mutation type and hearing phenotype(P>0.05). Conclusion:AS patients exhibit progressive hearing loss with significant heterogeneity over the long-term.. THearing loss is more likely to occur 5-6 years into the disease course. Hearing abnormalities are closely related to renal disease status, kidney tissue pathology, and gene mutations, emphasizing the need for vigilant long-term hearing follow-up and early intervention.
Male
;
Child
;
Female
;
Humans
;
Nephritis, Hereditary/pathology*
;
Retrospective Studies
;
Kidney
;
Deafness
;
Hearing Loss/genetics*
;
Kidney Failure, Chronic/pathology*
;
Mutation
5.Overview research of uremic ulearance granule treating chronic renal failure.
Xian-Jie MENG ; Yi-Gang WAN ; Qing-Xue WEI ; Hao-Li CHEN ; Xi-Miao SHI ; Yan-Ru HUANG ; Jian YAO
China Journal of Chinese Materia Medica 2013;38(21):3651-3655
The effective bioactivity compositions of uremic clearance granul (UCG) include isoflavonoids, emodin, astragaloside, paeoniflorin, salvianolic acid A, and so on. The effects of UCG treating chronic renal failure (CRF) in clinical pharmacodynamics mainly refer to improve renal function and the complications of CRF. The mechanisms involved in vivo basically include depressing transforming growth factor (TGF)-beta1 over-expression, lessening podocyte injury,inhibiting tubular epithelial myofibroblast transdifferentiation, ameliorating microinflammation status, retarding oxidative stress, and alleviating insulin resistance.
Animals
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Kidney
;
drug effects
;
metabolism
;
Kidney Failure, Chronic
;
drug therapy
;
genetics
;
metabolism
;
Oxidative Stress
;
drug effects
;
Transforming Growth Factor beta1
;
genetics
;
metabolism
6.Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies.
Soo Heon KWAK ; Kyong Soo PARK
Endocrinology and Metabolism 2015;30(2):147-158
Diabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage renal disease and amputation. Recently, genome-wide association studies (GWASs) have identified genetic risk factors for diabetic microvascular complications of retinopathy, nephropathy, and neuropathy. We summarized the recent findings of GWASs on diabetic microvascular complications and highlighted the challenges and our opinion on future directives. Five GWASs were conducted on diabetic retinopathy, nine on nephropathy, and one on neuropathic pain. The majority of recent GWASs were underpowered and heterogeneous in terms of study design, inclusion criteria and phenotype definition. Therefore, few reached the genome-wide significance threshold and the findings were inconsistent across the studies. Recent GWASs provided novel information on genetic risk factors and the possible pathophysiology of diabetic microvascular complications. However, further collaborative efforts to standardize phenotype definition and increase sample size are necessary for successful genetic studies on diabetic microvascular complications.
Amputation
;
Diabetic Retinopathy
;
Genetics
;
Genome-Wide Association Study*
;
Kidney Failure, Chronic
;
Neuralgia
;
Phenotype
;
Prevalence
;
Risk Factors
;
Sample Size
7.MTHFR C677T Polymorphism as a Risk Factor for Vascular Calcification in Chronic Hemodialysis Patients.
So Young LEE ; Hoe Young KIM ; Kyung Mi PARK ; Stephen Yon LEE ; Seong Geun HONG ; Hyung Jong KIM ; Dong Ho YANG
Journal of Korean Medical Science 2011;26(3):461-465
Polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T is one of the suggested risk factors for atherosclerosis. However, few studies have reported on the relationship between MTHFR C677T polymorphism and vascular calcification (VC) in chronic hemodialysis patients. We investigated the relationship between the MTHFR C677T polymorphism and VC in 152 chronic hemodialysis patients. Patients with a TT genotype exhibited significantly higher VC scores than patients expressing CC and CT (P = 0.002). The prevalence of peripheral vascular disease increased with the incidence of MTHFR C677T mutations for all patients, and the incidence of cerebrovascular accidents also increased with the presence of mutations for young patients (< or = 60 yr) (P < 0.05). Patients with CT and TT genotypes had adjusted odds ratios for VC of 1.39 and 1.58, respectively (P < 0.05). In summary, these data suggest that the MTHFR C677T polymorphism affects the degree of VC in chronic hemodialysis patients.
Aged
;
Calcinosis/*genetics
;
Genetic Predisposition to Disease
;
Humans
;
Kidney Failure, Chronic/*genetics
;
Methylenetetrahydrofolate Reductase (NADPH2)/*genetics
;
Middle Aged
;
*Polymorphism, Single Nucleotide
;
*Renal Dialysis
;
Risk Factors
;
Vascular Diseases/*genetics
8.Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Kyu Beck LEE ; Un Kyung KIM ; Chung Choo LEE
Journal of Korean Medical Science 2000;15(4):431-435
Renin-angiotensin system is considered important in the genesis of hypertension and development of end-stage renal disease (ESRD) in autosomal dominant polycystic kidney disease (ADPKD). The angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been associated with susceptibility to the development of some renal diseases. We investigated the association of ACE gene polymorphism with the progression to hypertension and ESRD in 108 patients with ADPKD. The ACE I/D polymorphism was amplified with the flanking primers by polymerase chain reaction. In patients genotyped for ACE gene polymorphism, the frequencies of DD (15+ACU-), ID (51+ACU-) and II (34+ACU-) genotypes were similar to those of the general population. Of the 108 patients, 64 (59+ACU-) developed hypertension and 24 (22+ACU-) reached ESRD at the time of study. The prevalence of hypertension was not significantly different among the three genotypes. The mean renal survival time was 53-6 yr in II genotype, 5510 yr in ID genotype and 529 yr in DD genotype which was not significantly different among them. Cumulative renal survival was not significantly different either. There was no association of ACE gene polymorphism with the prevalence of hypertension and renal survival in ADPKD. We suggest that ACE I/D polymorphism is not an important modifying gene in the progression of ADPKD.
Adult
;
Aged
;
Comparative Study
;
Disease Progression
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Human
;
Hypertension, Renal/etiology
;
Hypertension, Renal/epidemiology
;
Kidney Failure, Chronic/etiology
;
Kidney Failure, Chronic/epidemiology
;
Korea/epidemiology
;
Male
;
Middle Age
;
Peptidyl-Dipeptidase A/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/epidemiology
;
Polycystic Kidney, Autosomal Dominant/enzymology
;
Polycystic Kidney, Autosomal Dominant/complications
;
Polymerase Chain Reaction
;
Polymorphism (Genetics)+ACo-
;
Prevalence
9.Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Kyu Beck LEE ; Un Kyung KIM ; Chung Choo LEE
Journal of Korean Medical Science 2000;15(4):431-435
Renin-angiotensin system is considered important in the genesis of hypertension and development of end-stage renal disease (ESRD) in autosomal dominant polycystic kidney disease (ADPKD). The angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been associated with susceptibility to the development of some renal diseases. We investigated the association of ACE gene polymorphism with the progression to hypertension and ESRD in 108 patients with ADPKD. The ACE I/D polymorphism was amplified with the flanking primers by polymerase chain reaction. In patients genotyped for ACE gene polymorphism, the frequencies of DD (15+ACU-), ID (51+ACU-) and II (34+ACU-) genotypes were similar to those of the general population. Of the 108 patients, 64 (59+ACU-) developed hypertension and 24 (22+ACU-) reached ESRD at the time of study. The prevalence of hypertension was not significantly different among the three genotypes. The mean renal survival time was 53-6 yr in II genotype, 5510 yr in ID genotype and 529 yr in DD genotype which was not significantly different among them. Cumulative renal survival was not significantly different either. There was no association of ACE gene polymorphism with the prevalence of hypertension and renal survival in ADPKD. We suggest that ACE I/D polymorphism is not an important modifying gene in the progression of ADPKD.
Adult
;
Aged
;
Comparative Study
;
Disease Progression
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Human
;
Hypertension, Renal/etiology
;
Hypertension, Renal/epidemiology
;
Kidney Failure, Chronic/etiology
;
Kidney Failure, Chronic/epidemiology
;
Korea/epidemiology
;
Male
;
Middle Age
;
Peptidyl-Dipeptidase A/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/genetics+ACo-
;
Polycystic Kidney, Autosomal Dominant/epidemiology
;
Polycystic Kidney, Autosomal Dominant/enzymology
;
Polycystic Kidney, Autosomal Dominant/complications
;
Polymerase Chain Reaction
;
Polymorphism (Genetics)+ACo-
;
Prevalence
10.Expression of ghrelin and its receptor GHS-R in the hypothalamus and gastrointestinal tract in rats with chronic renal failure.
Rong-guo FU ; Hao-zheng YUAN ; Li WANG ; Heng GE ; Jun ZHANG ; Qi-lan NING ; Fu-jun ZHANG
Journal of Southern Medical University 2011;31(1):96-99
OBJECTIVETo investigate the expression of ghrelin and its receptor, growth hormone secretagogue receptor (GHS-R), in the hypothalamus and gastrointestinal tract in rats with chronic renal failure (CRF) and explore their relationship with the disorder of gastrointestinal tract motility.
METHODSSD rats were randomly divided into sham-operated group (n=8) and CRF group (n=16), and in the latter group, the rats were subjected to 5/6 nephrectomy to induce CRF. Real-time PCR and immunohistochemical staining were used to detect the distribution of mRNA and protein of ghrelin and GHS-R in the gastric fundus, duodenum, and hypothalamus.
RESULTSThe rats in the CRF group showed a significantly higher expression of ghrelin mRNA and protein in the gastric fundus but a lower expression in the hypothalamus than those in the sham-operated group (P<0.01), but the expression in the duodenum was similar between the two groups (P>0.05). The expression of GHS-R mRNA and protein in the gastric fundus was significantly higher in the CRF group than in the sham-operated group (P<0.01), while in the hypothalamus and duodenum, the expression was significantly lower in the CRF group (P<0.01).
CONCLUSIONThe different distribution patterns of ghrelin and GHS-R in the tissues may be an important pathological basis of gastrointestinal motility disorder in CRF.
Animals ; Gastrointestinal Tract ; metabolism ; Ghrelin ; genetics ; metabolism ; Hypothalamus ; metabolism ; Kidney Failure, Chronic ; metabolism ; Male ; RNA, Messenger ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Ghrelin ; genetics ; metabolism